Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub

Jennifer Franklin
Director, CMC Regulatory Affairs at Ionis Pharmaceuticals
Speaker

Profile

Jenny has worked for Ionis Pharmaceuticals, Inc. in Carlsbad, CA, for 12 years. For the past two, she has been responsible for CMC Regulatory Affairs for Ionis’ late phase/commercial compounds, as well as all development compounds. Prior to that, she was responsible for Quality Assurance oversight of oligonucleotide drug substance manufacturing and testing activities, and associated functions. Before joining Ionis, Jenny worked in Quality Control for Gala Biotech (now Catalent BioPharma) in Middleton, WI. She earned her B.S in Biology and French from the University of Wisconsin.

Agenda Sessions

  • Doing an IND with An NDA in Mind: Planning for Regulatory Interactions

    On Demand - Premium Only